Tag Archives: Mark Geier

Mark Blaxill Admits COI When His Undermining Began

conflict

By Jake Crosby

Mark Blaxill appeared on Linderman Unleashed Thursday to “rebut” my interview with Linderman last week (both interviews embedded below). Unfortunately, Blaxill avoided much of what I said despite admitting he’d had a conflict of interest with vaccine manufacturers while David Kirby was writing the book “Evidence of Harm.” Mark Blaxill also made tacit reference to my autism – and not in a positive way – near the end of the interview.

In Kirby’s book, Blaxill was quoted as threatening to resign from SafeMinds‘ board should the organization speak out against drug companies poisoning children – companies that he admitted at the time were clients of his then-employer, Boston Consulting Group. The period when Evidence of Harm was still being written also corresponds with when Blaxill and others from SafeMinds were secretly advising the Vaccine Injured Petitioners’ Steering Committee for the autism omnibus, where he trashed petitioners’ expert witnesses Dr. Mark and David Geier and said Dr. Andrew Wakefield’s work was “not well-supported by the epi data.” Blaxill did all this despite his connections to the vaccine industry. He claimed on the show that “no one worked harder” than he did in showing how CDC cheated with numbers using the Vaccine Safety Datalink, and yet, it was David Geier not Mark Blaxill who discovered the CDC’s early results showing thimerosal caused harm including autism.

It should  be stated that while on Linderman, Blaxill also denied possessing a conflict of interest any longer – claiming to not have one since 2006. Nonetheless, the troubling trend of his undermining advocacy against vaccines causing autism began during his employment with the Boston Consulting Group, which has vaccine manufacturers for clients.

The latest example of this trend can be seen in the congressional autism hearings in which Mark Blaxill has been consistently working to prevent CDC malfeasance from being exposed both before Congress and on national television via dishonest lobbying practices. While Mark Blaxill chaired SafeMinds’ Government Affairs Committee, SafeMinds succeeded in changing the topic of last November’s hearing so it would no longer be about CDC malfeasance as originally planned and organized by autism parent and scientist Dr. Brian Hooker. Blaxill and SafeMinds’ actions prevented Dr. Hooker from testifying.*

In a more recent example of such undermining, Mark Blaxill’s Canary Party released an action alert asking Congress to investigate the National Vaccine Injury Compensation Program last April – a complete betrayal of trust to Dr. Brian Hooker. Just two weeks prior, Canary Party President Jennifer Larson had promised Dr. Hooker that the alert would ask Congress to hold the next hearing specifically on CDC malfeasance, which the last hearing would have been about had SafeMinds not changed the topic. Age of Autism – both sponsored and edited by Blaxill – covered up such revelations about the alert by refusing to publish my critical comment on the pretense it was “picayune.”

Yet in spite of these activities – SafeMinds’ lobbying, Canary Party’s action alert and most recently Canary Party President Jennifer Larson’s $40,000 contribution the PAC of Congressional Committee Chair Darrell Issa – Mark Blaxill insists any involvement of his in sabotaging the hearing is “a lie” and that he has “no power” over how the hearing topics are chosen or who is invited to testify. While Issa, other congressmen and their staffers have the final say, Mark Blaxill consistently avoids discussing his ongoing role in attempting to influence their decisions to keep exposure of the vaccine-autism cover-up out of the hearings.

Instead, he denies having any explanation for all the failures that have occurred concerning the hearings and similar initiatives – many of which he contributed to – and essentially blames his followers for not being rich and powerful enough to defeat DHHS or big pharma rather than his own largely self-styled and unwanted leadership. He told Linderman:

“To be honest, you know we’re fighting with pop guns, man, and the other side has tanks…but you go to war with the army that you got, not the one that you wish for. And the fact is, we’re not making enough change, and I don’t know what to do about it to be honest, other than to keep fighting and to keep fighting the best way that we can.”

And that would be, according to Mark Blaxill, with the analogous equivalent of pop guns fighting tanks while he thwarts yet another hearing and his vice president Ginger Taylor tells people my judgement is compromised by my autism. At the end of the interview (which began with my name being stated by Curt Linderman as the very reason for the interview), Blaxill clearly made another derogatory reference to my autism without naming me:

I think we need to love our kids whether they’re  low-functioning or high-functioning, and when they’re high-functioning and they’re not functioning the way we hope they would, we love them anyway. 

Yet just days after my first article on how SafeMinds hijacked the last congressional hearing went online, he unfriended me on Facebook. I guess I really must not be functioning the way Mark Blaxill hoped.

Interviews:

Mark Blaxill’s response

My interview on Linderman

*Linderman mistakenly asked Blaxill to verify if the Canary Party influenced the November hearing when it was actually SafeMinds’ involvement in that hearing that I had taken issue with during my interview. I had also noted that Blaxill’s base of operations later shifted from SafeMinds to Canary Party in his efforts to influence Congress.

 

Jake Crosby is editor of Autism Investigated and is diagnosed with an autism spectrum disorder. He is a 2011 graduate of Brandeis University with a Bachelor of Arts in both History and Health: Science, Society and Policy and a 2013 graduate of The George Washington University School of Public Health and Health Services with a Master of Public Health in Epidemiology. He currently attends the University of Texas School of Public Health where he is studying for a Ph.D. in Epidemiology.